TBPH — THERAVANCE BIOPHARMA INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 187 家机构在其最新 13F 申报中持有 TBPH(THERAVANCE BIOPHARMA INC),合计申报市值 $820.96M,对应 48.38M 股。按股数计算较上季度减持 1.6%(-755.52K 股),申报市值环比上升 3.0%。持仓集中度较高:前五大持有人占申报市值的 56.8%,前十大的集中度为 70.2%。
与上一季度相比,38 家新建仓位、69 家加仓、54 家减仓、30 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
THERAVANCE BIOPHARMA INC(TBPH)的主要机构持有人包括 HIGHBRIDGE CAPITAL MANAGEMENT LLC、Madison Avenue Partners, LP、Weiss Asset Management LP,按 13F 申报市值在本页 310 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 3 | 27.76K | $472.75K | +787.6% |
| Q2 2026 | 187 | 48.38M | $820.96M | -1.6% |
| Q1 2026 | 178 | 49.95M | $809.48M | +0.5% |
| Q4 2025 | 176 | 50.35M | $940.15M | +1.8% |
| Q3 2025 | 163 | 48.84M | $712.10M | +0.6% |
| Q2 2025 | 137 | 47.09M | $518.76M | +4.4% |
| Q1 2025 | 130 | 44.95M | $400.83M | -0.3% |
| Q4 2024 | 129 | 44.63M | $419.35M | +0.2% |
表内 8 个季度中,机构持股合计减少 100%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2025(+4.4%)。
前 25 大机构持仓人(Q3 2026) — 3 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 27.43K | $467.00K | 0.09% | 增持 | |
| 335 | $5.70K | 0.00% | 持有 | |
| 3 | $51 | 0.00% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.51M | $154.37M | 6.71% | 持有 | |
| 7.46M | $121.03M | 3.26% | 持有 | |
| 4.84M | $78.58M | 8.40% | 增持 | |
| 4.30M | $69.73M | 0.00% | 增持 | |
| 2.76M | $44.81M | 3.31% | 持有 | |
| 1.78M | $28.95M | 0.00% | 新进 | |
| 1.30M | $21.06M | 0.00% | 增持 | |
| 1.26M | $20.43M | 0.03% | 增持 | |
| 1.14M | $18.46M | 0.00% | 增持 | |
| 983.62K | $15.96M | 0.00% | 增持 | |
| 954.04K | $15.48M | 0.01% | 减持 | |
| 954.04K | $15.48M | 0.03% | 减持 | |
| 764.11K | $12.40M | 0.01% | 增持 | |
| 583.49K | $9.47M | 0.72% | 减持 | |
| 510.27K | $8.28M | 0.00% | 减持 | |
| 416.14K | $6.75M | 0.00% | 增持 | |
| 409.44K | $6.65M | 0.00% | 增持 | |
| 404.15K | $6.56M | 0.01% | 持有 | |
| 400.76K | $6.50M | 0.00% | 新进 | |
| 378.98K | $6.15M | 0.00% | 减持 | |
| 370.53K | $6.01M | 0.00% | 增持 | |
| 328.68K | $5.33M | 0.02% | 增持 | |
| 327.55K | $5.32M | 0.00% | 减持 | |
| 310.59K | $5.04M | 0.00% | 减持 | |
| 310.59K | $5.04M | 0.00% | 减持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.51M | $177.95M | 7.64% | 持有 | |
| 7.46M | $139.52M | 2.23% | 持有 | |
| 4.30M | $80.45M | 9.25% | 减持 | |
| 4.05M | $75.79M | 0.00% | 持有 | |
| 2.76M | $51.66M | 6.77% | 持有 | |
| 2.37M | $44.29M | 0.00% | 增持 | |
| 1.26M | $23.57M | 0.01% | 增持 | |
| 1.26M | $23.57M | 0.05% | 增持 | |
| 1.10M | $20.62M | 0.00% | 增持 | |
| 963.26K | $18.02M | 0.01% | 增持 | |
| 938.72K | $17.57M | 0.00% | 增持 | |
| 858.96K | $16.07M | 0.00% | 增持 | |
| 803.12K | $15.03M | 0.00% | 增持 | |
| 727.16K | $13.61M | 0.96% | 减持 | |
| 570.42K | $10.67M | 0.01% | 增持 | |
| 537.34K | $10.05M | 0.02% | 增持 | |
| 473.50K | $8.86M | 0.02% | 增持 | |
| 418.63K | $7.83M | 0.01% | 增持 | |
| 416.41K | $7.79M | 0.00% | 增持 | |
| 404.14K | $7.56M | 0.01% | 减持 | |
| 400.50K | $7.49M | 0.00% | 增持 | |
| 379.50K | $7.10M | 0.01% | 增持 | |
| 351.25K | $6.57M | 0.33% | 增持 | |
| 338.96K | $6.34M | 0.02% | 新进 | |
| 329.93K | $6.17M | 0.00% | 减持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.51M | $138.86M | 8.29% | 持有 | |
| 7.46M | $108.87M | 2.37% | 持有 | |
| 4.95M | $72.27M | 8.85% | 持有 | |
| 4.07M | $59.41M | 0.00% | 减持 | |
| 2.76M | $40.31M | 7.92% | 持有 | |
| 2.21M | $32.29M | 0.00% | 增持 | |
| 1.28M | $18.75M | 1.82% | 减持 | |
| 1.21M | $17.66M | 0.04% | 增持 | |
| 1.21M | $17.66M | 0.01% | 增持 | |
| 1.12M | $16.34M | 2.93% | 持有 | |
| 1.06M | $15.42M | 0.00% | 增持 | |
| 897.99K | $13.11M | 0.00% | 持有 | |
| 766.70K | $11.19M | 0.00% | 增持 | |
| 726.78K | $10.61M | 0.01% | 新进 | |
| 599.55K | $8.75M | 0.00% | 增持 | |
| 527.11K | $7.70M | 0.00% | 减持 | |
| 514.17K | $7.51M | 0.00% | 增持 | |
| 414.71K | $6.05M | 0.01% | 增持 | |
| 373.60K | $5.45M | 0.01% | 减持 | |
| 357.65K | $5.22M | 0.01% | 增持 | |
| 341.31K | $4.98M | 0.00% | 减持 | |
| 320.14K | $4.67M | 0.00% | 增持 | |
| 320.14K | $4.67M | 0.00% | 增持 | |
| 310.70K | $4.54M | 0.14% | 新进 | |
| 264.31K | $3.86M | 0.15% | 持有 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.51M | $104.91M | 7.00% | 持有 | |
| 7.46M | $82.25M | 1.47% | 持有 | |
| 4.95M | $54.60M | 8.27% | 增持 | |
| 4.14M | $45.65M | 0.00% | 增持 | |
| 2.76M | $30.45M | 6.66% | 持有 | |
| 2.16M | $23.80M | 0.00% | 增持 | |
| 1.80M | $19.84M | 1.56% | 持有 | |
| 1.12M | $12.34M | 1.71% | 持有 | |
| 1.04M | $11.42M | 0.00% | 减持 | |
| 1.00M | $11.05M | 0.03% | 增持 | |
| 1.00M | $11.05M | 0.01% | 增持 | |
| 893.98K | $9.86M | 0.00% | 持有 | |
| 722.07K | $7.97M | 0.00% | 增持 | |
| 550.61K | $6.07M | 0.00% | 增持 | |
| 539.64K | $5.95M | 0.00% | 增持 | |
| 503.62K | $5.55M | 0.00% | 增持 | |
| 485.33K | $5.35M | 0.01% | 增持 | |
| 397.13K | $4.38M | 0.00% | 减持 | |
| 387.47K | $4.27M | 0.01% | 增持 | |
| 352.23K | $3.89M | 0.00% | 增持 | |
| 303.89K | $3.35M | 0.00% | 增持 | |
| 303.89K | $3.35M | 0.00% | 增持 | |
| 276.89K | $3.05M | 0.06% | 增持 | |
| 264.31K | $2.92M | 0.15% | 增持 | |
| 208.78K | $2.30M | 0.00% | 持有 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 1.12M 股 · $19.01M
- Jupiter Topco LLC 387.49K 股 · $6.59M
- Sixth Street Partners Management Company, L.P. 321.15K 股 · $5.46M
- GLAZER CAPITAL, LLC 301.83K 股 · $5.13M
- WEDGE CAPITAL MANAGEMENT L L P/NC 128.84K 股 · $2.19M
- Millennium Management 115.40K 股 · $1.96M
- MILLENNIUM MANAGEMENT LLC 115.40K 股 · $1.96M
- Schonfeld Strategic Advisors LLC 108.88K 股 · $1.85M
- SIERRA SUMMIT ADVISORS LLC 59.10K 股 · $1.00M
- SEGALL BRYANT & HAMILL, LLC 56.05K 股 · $952.88K
- MONEY CONCEPTS CAPITAL CORP 41.85K 股 · $711.42K
- Groupe la Francaise 30.00K 股 · $510.00K
完全清仓(较上季)
- STATE STREET CORP 卖出 1.30M 股 · $21.06M
- Assenagon Asset Management S.A. 卖出 404.15K 股 · $6.56M
- Janus Henderson Group 卖出 378.98K 股 · $6.15M
- Arrowstreet Capital 卖出 327.55K 股 · $5.32M
- Pacer Advisors, Inc. 卖出 293.19K 股 · $4.76M
- 683 Capital Management, LLC 卖出 250.00K 股 · $4.06M
- Caption Management, LLC 卖出 163.70K 股 · $2.66M
- Verition Fund Management LLC 卖出 110.00K 股 · $1.79M
- Marble Bar Asset Management LLP 卖出 85.07K 股 · $1.38M
- Precision Wealth Strategies, LLC 卖出 62.81K 股 · $1.02M
- Empowered Funds, LLC 卖出 55.46K 股 · $900.16K
- EntryPoint Capital, LLC 卖出 49.74K 股 · $807.26K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mint Tower Capital Management B.V. | 27.43K | 2.79K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Allworth Financial LP | 335 | 335 | 241 | 274 | 212 | 163 | 43 | 134 | — | — | — | 178 | 13 | — | — | — | — | — | — | — |
| IFP Advisors, Inc | 3 | 3 | 3 | 3 | 3 | — | — | 32 | — | — | — | — | — | — | — | — | — | — | — | — |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | — | — | — | — | — | — | — | — | — | — | — | 166.23K | 227.30K | — | — | — | — | — | — | — |
| Madison Avenue Partners, LP | — | 9.21M | 9.51M | 9.51M | 9.51M | 9.51M | 9.51M | 9.51M | 9.51M | 8.51M | 7.01M | 7.01M | 7.01M | — | — | — | — | — | — | — |
| Weiss Asset Management LP | — | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | — | — | — | — | — | — | — |
| Newtyn Management, LLC | — | 3.43M | 4.84M | 4.30M | 4.95M | 4.95M | 4.76M | 4.76M | 4.50M | 2.12M | 1.64M | 1.90M | 1.84M | — | — | — | — | — | — | — |
| BlackRock Inc | — | 4.56M | 4.30M | 4.05M | 4.07M | 4.14M | 3.45M | 3.71M | 3.73M | — | — | — | — | — | — | — | — | — | — | — |
| BAUPOST GROUP LLC/MA | — | — | — | — | — | — | — | — | — | 4.20M | 6.59M | — | — | — | — | — | — | — | — | — |
| Irenic Capital Management LP | — | 2.76M | 2.76M | 2.76M | 2.76M | 2.76M | 2.76M | 2.76M | 2.76M | 2.76M | 2.76M | 2.76M | 2.76M | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | 2.37M | 2.21M | 2.16M | 2.08M | 2.01M | 2.05M | 2.00M | 2.69M | 3.49M | 3.84M | 4.22M | 5.63M | 5.56M | 6.01M | 6.54M | 6.95M | 6.30M |
| VANGUARD CAPITAL MANAGEMENT LLC | — | 1.77M | 1.78M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pictet Asset Management Holding SA | — | — | — | — | — | — | — | — | 684.89K | 878.65K | 2.04M | 2.17M | 2.01M | — | — | — | — | — | — | — |
| D. E. Shaw & Co | — | 1.19M | 954.04K | 1.26M | 1.21M | 1.00M | 920.30K | 833.94K | 764.76K | 758.08K | 781.59K | 851.21K | 689.56K | 714.11K | 1.01M | 1.57M | 1.59M | 1.38M | 1.24M | 876.46K |
| D. E. Shaw & Co., Inc. | — | 1.19M | 954.04K | 1.26M | 1.21M | 1.00M | 920.30K | 833.94K | 764.76K | 758.08K | 781.59K | 851.21K | 689.56K | — | — | — | — | — | — | — |
| STATE STREET CORP | — | — | 1.30M | 1.10M | 1.06M | 1.04M | 1.07M | 1.22M | 1.19M | 1.27M | 1.37M | 1.39M | 1.47M | — | — | — | — | — | — | — |
| Two Sigma Investments | — | 1.23M | 1.26M | 537.34K | 231.27K | 17.79K | — | — | — | 49.52K | — | 38.94K | — | 58.06K | 356.87K | 962.83K | 652.87K | — | 149.24K | 35.07K |
| Park West Asset Management LLC | — | — | — | 181.51K | 1.28M | 1.80M | 1.80M | 1.79M | 1.86M | 1.70M | 1.16M | 900.00K | 1.98M | — | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 1.12M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | — | 1.12M | 1.14M | 938.72K | 897.99K | 893.98K | 890.57K | 862.80K | 857.98K | 857.39K | 967.45K | 994.00K | 1.06M | 1.17M | 1.19M | 1.14M | 1.08M | 1.03M | 1.01M | 1.04M |
常见问题
Which funds hold TBPH?
As of 2026-Q2, 187 institutional funds reported holding TBPH (THERAVANCE BIOPHARMA INC) in SEC 13F filings, with a combined reported value of $820.96M.
How many shares of TBPH do institutions own?
13F filers reported 48.38M shares of TBPH, worth $820.96M in aggregate at the end of 2026-Q2.
Is institutional ownership of TBPH rising or falling?
Share counts moved -1.6% versus the prior quarter — distribution.
Who are the top institutional holders of TBPH?
The largest 13F holders are HIGHBRIDGE CAPITAL MANAGEMENT LLC, Madison Avenue Partners, LP, Weiss Asset Management LP, BlackRock Inc, Newtyn Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of THERAVANCE BIOPHARMA INC?
The major shareholders of THERAVANCE BIOPHARMA INC (TBPH) by reported 13F value are HIGHBRIDGE CAPITAL MANAGEMENT LLC, Madison Avenue Partners, LP, Weiss Asset Management LP, BlackRock Inc, Newtyn Management, LLC, among 310 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.